What are mega cisterna magna and posterior cranial fossa arachnoid cysts, and what is their typical management?

Mega Cisterna Magna and Posterior Cranial Fossa Arachnoid Cysts: Definitions and Management

Mega cisterna magna (MCM) is an enlarged cisterna magna measuring >10 mm in the anteroposterior dimension without cerebellar or vermian malformations, while posterior fossa arachnoid cysts are benign CSF-filled cysts within the intra-arachnoid space that constitute approximately 1% of intracranial masses 1, 2.

Key Anatomical Distinctions

Mega Cisterna Magna

• Anatomical variant (not a true pathology) with enlarged cisterna magna >10 mm anteroposterior dimension
• Normal cerebellar vermis and hemispheres
• No mass effect on surrounding structures
• Usually discovered incidentally on prenatal ultrasound or neuroimaging 1

Posterior Fossa Arachnoid Cysts

• True pathological cysts containing CSF within the arachnoid space
• Most commonly located in cerebellopontine angle (CPA), though can extend dorsally to brainstem or into internal auditory canal 3
• May cause mass effect on brainstem, cranial nerves, or fourth ventricle
• Present with symptoms including headaches, seizures, focal neurologic deficits, hearing loss, or obstructive hydrocephalus 2

Critical Differential Diagnosis

Distinguishing MCM from other posterior fossa malformations is essential, as management differs dramatically:

• Blake's pouch cyst: Communication with fourth ventricle
• Dandy-Walker malformation: Vermian hypoplasia/agenesis with cystic dilatation of fourth ventricle
• Arachnoid cyst: Discrete cyst wall, no communication with ventricular system 4, 5

MRI is the preferred imaging modality for differentiation, providing superior visualization of cerebellar structures and cyst characteristics 2, 4.

Management Algorithm

For Mega Cisterna Magna

Observation is the standard approach for asymptomatic MCM, as it represents a benign anatomical variant 1. No surgical intervention is indicated unless:

• Development of symptomatic hydrocephalus (rare)
• Progressive neurologic symptoms attributable to mass effect

For Posterior Fossa Arachnoid Cysts

Symptomatic cysts require surgical intervention, with approach determined by location and presentation:

Asymptomatic Small Cysts (<10 mm)

• Observation with serial MRI monitoring 6
• Similar follow-up protocol as for pituitary incidentalomas

Symptomatic or Large Cysts

Neuroendoscopic fenestration is the first-line surgical approach 7, 8:

• Lower morbidity than open craniotomy
• Avoids shunt-related complications (infection, malfunction, overdrainage)
• Particularly effective for lateral CPA cysts via retromastoid burr hole approach

Open microsurgical resection via suboccipital retrosigmoid approach when 3:

• Endoscopic approach fails or is technically not feasible
• Strong adherence to neurovascular structures
• Need for radical cyst wall excision to prevent recurrence
• Long-term follow-up (mean 3.3 years) shows excellent outcomes with this approach

Cysts with Obstructive Hydrocephalus

CSF diversion takes priority 8:

1. Endoscopic third ventriculostomy (ETV) via frontal burr hole
2. In selected cases, transaqueductal trans-Magendie approach allows both ETV and direct cyst fenestration
3. Ventriculoperitoneal shunt only if endoscopic options fail

Important Clinical Pitfalls

Do not confuse MCM with symptomatic arachnoid cysts—MCM requires no treatment while arachnoid cysts may need surgery 1, 3.

Assess for vertebral artery hypoplasia in patients with posterior fossa cysts presenting with vertebrobasilar insufficiency symptoms, as reduced vertebral artery diameter (particularly left-sided) strongly correlates with these symptoms 9.

Evaluate for associated malformations: Approximately 21.9% of patients with posterior fossa cysts have coexisting MCM 9. Systematic imaging assessment prevents missed diagnoses.

Avoid shunt placement as first-line therapy for isolated arachnoid cysts without hydrocephalus—endoscopic fenestration provides superior outcomes with fewer complications 7, 8.